Diabetes treatment is constantly advancing, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of naturally occurring hormones involved in bloodglucose regulation. These novel agents demonstrate significant potential in managing

The management of diabetes continues to evolve with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising mechanisms for controlling blood sugar levels and may improve the lives of individuals living with diabetes. This